|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Syros Pharmaceuticals Inc. (SYRS)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-01-31 Purchase |
2018-02-02 3:53 pm |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
209,424 | $9.55 | $1,999,999 | 1,059,938 (Indirect) |
View |
| 2017-12-15 Purchase |
2017-12-15 4:02 pm |
Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer |
15,000 | $9.084 | $136,260 | 15,000 (Direct) |
View |
| 2017-12-12 Purchase |
2017-12-14 8:22 pm |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
109,774 | $9.033 | $991,558 | 830,494 (Indirect) |
View |
| 2017-10-23 Sale |
2017-10-23 4:44 pm |
Syros Pharmaceuticals Inc. | SYRS | DeSimone Colleen Elizabeth Principal Accounting Officer |
550 | $16.06 | $8,833 | 13,016 (Direct) |
View |
| 2017-08-14 Sale |
2017-08-16 4:08 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
3,282 | $22 | $72,204 | 420,101 (Direct) |
View |
| 2017-08-07 Sale |
2017-08-08 5:20 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
2,500 | $23.59 | $58,969 | 110,075 (Direct) |
View |
| 2017-07-25 Sale |
2017-07-27 4:09 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
12,500 | $21.85 | $273,125 | 25,025 (Direct) |
View |
| 2017-07-25 Sale |
2017-07-27 4:09 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
3,282 | $22.09 | $72,496 | 423,383 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported Date |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-03-12 Option Award |
2018-03-12 5:10 pm |
N/A 2028-03-11 |
Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr Chief Financial Officer |
150,000 | $12.32 | 150,000 (Direct) |
View |
| 2018-03-12 Option Award |
2018-03-12 5:10 pm |
N/A 2028-03-11 |
Syros Pharmaceuticals Inc. | SYRS | Ferra Joseph J Jr Chief Financial Officer |
50,000 | $12.32 | 150,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:09 pm |
N/A 2028-02-15 |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer |
75,000 | $10.09 | 75,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:09 pm |
2018-02-16 2026-09-26 |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer |
11,666 | $13.3 | 75,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:08 pm |
N/A 2028-02-15 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
75,000 | $10.09 | 75,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:08 pm |
N/A 2028-02-15 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
75,000 | $10.09 | 75,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:08 pm |
N/A 2028-02-15 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO Director |
285,000 | $10.09 | 285,000 (Direct) |
View |
| 2017-11-13 Option Award |
2017-11-14 5:15 pm |
N/A 2027-11-12 |
Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer |
150,000 | $11.65 | 150,000 (Direct) |
View |
| 2017-11-13 Option Award |
2017-11-14 5:15 pm |
N/A 2027-11-12 |
Syros Pharmaceuticals Inc. | SYRS | Springhorn Jeremy P. Chief Business Officer |
50,000 | $11.65 | 150,000 (Direct) |
View |
| 2017-10-23 Exercise |
2017-10-23 4:44 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | DeSimone Colleen Elizabeth Principal Accounting Officer |
550 | $3.04 | 13,016 (Direct) |
View |
| 2017-10-23 Exercise |
2017-10-23 4:44 pm |
N/A 2025-06-08 |
Syros Pharmaceuticals Inc. | SYRS | DeSimone Colleen Elizabeth Principal Accounting Officer |
550 | $3.04 | 13,016 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:20 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | NELSEN ROBERT Director 10% Owner |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:20 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:20 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | SHARP PHILIP A Director |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:20 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | SATO VICKI L Director |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:19 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Patel Sanj K Director |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:19 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:19 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
11,000 | $14.62 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-09-22 5:19 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
22,000 | $14.62 | 22,000 (Direct) |
View |
| 2017-08-17 Other |
2017-08-21 4:19 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship VentureLabs IV LLC Flagship Ventures Fund IV General Partner LLC AFEYAN NOUBAR KANIA EDWIN M JR 10% Owner |
1,295,997 | $0 | 2,378,663 (Direct) |
View |
| 2017-08-17 Other |
2017-08-21 4:19 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship VentureLabs IV LLC Flagship Ventures Fund IV General Partner LLC AFEYAN NOUBAR KANIA EDWIN M JR 10% Owner |
306,222 | $0 | 2,378,663 (Indirect) |
View |
| 2017-08-17 Other |
2017-08-21 4:19 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship VentureLabs IV LLC Flagship Ventures Fund IV General Partner LLC AFEYAN NOUBAR KANIA EDWIN M JR 10% Owner |
54,293 | $0 | 2,378,663 (Indirect) |
View |
| 2017-08-07 Exercise |
2017-08-08 5:20 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
2,500 | $1.01 | 110,075 (Direct) |
View |
| 2017-08-07 Exercise |
2017-08-08 5:20 pm |
N/A 2023-05-22 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
2,500 | $1.01 | 110,075 (Direct) |
View |
| 2017-07-25 Exercise |
2017-07-27 4:09 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
12,500 | $1.01 | 25,025 (Direct) |
View |
| 2017-07-25 Exercise |
2017-07-27 4:09 pm |
N/A 2023-05-22 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
12,500 | $1.01 | 25,025 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:04 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
22,000 | $14.26 | 22,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:04 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:03 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:03 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Patel Sanj K Director |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:03 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | NELSEN ROBERT Director 10% Owner |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:03 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | SATO VICKI L Director |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:02 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | SHARP PHILIP A Director |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-12 4:02 pm |
N/A 2027-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
11,000 | $14.26 | 11,000 (Direct) |
View |
| 2017-02-10 Option Award |
2017-02-13 5:17 pm |
N/A 2027-02-09 |
Syros Pharmaceuticals Inc. | SYRS | Kuvalanka Kyle D. Chief Operating Officer |
78,000 | $10.9 | 78,000 (Direct) |
View |
| 2017-02-10 Option Award |
2017-02-13 5:17 pm |
N/A 2027-02-09 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO Director |
175,000 | $10.9 | 175,000 (Direct) |
View |
| 2017-02-10 Option Award |
2017-02-13 5:16 pm |
N/A 2027-02-09 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
63,500 | $10.9 | 63,500 (Direct) |
View |
| 2017-02-10 Option Award |
2017-02-13 5:16 pm |
N/A 2027-02-09 |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer |
40,000 | $10.9 | 40,000 (Direct) |
View |
| 2017-02-10 Option Award |
2017-02-13 5:16 pm |
N/A 2027-02-09 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
63,500 | $10.9 | 63,500 (Direct) |
View |
| 2017-01-27 Option Award |
2017-01-30 08:42 am |
N/A 2027-01-26 |
Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director |
22,000 | $10.76 | 22,000 (Direct) |
View |
| 2016-09-27 Option Award |
2016-09-29 5:11 pm |
N/A 2026-09-26 |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal Officer |
105,000 | $13.3 | 105,000 (Direct) |
View |
| 2016-09-16 Option Award |
2016-09-19 06:59 am |
N/A 2026-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO Director |
75,000 | $12.17 | 75,000 (Direct) |
View |
| 2016-09-15 Option Award |
2016-09-19 06:57 am |
N/A 2026-09-14 |
Syros Pharmaceuticals Inc. | SYRS | SATO VICKI L Director |
22,000 | $12.59 | 22,000 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Thu, 24 May 2018 10:50:12 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |